This announcement speaks as much to health as to the economy. The Swiss company Roche, a global giant in pharmaceuticals and diagnostics, has announced it has obtained CE marking for a test to detect Alzheimer's disease. Its name: Elecsys pTau217. Its principle: to measure the phosphorylated protein tau-217 in the blood, considered a marker…
